Author:
Sun Yixiang,Li Guanglei,Zhang Hanlin,Xie Mao
Funder
Yantai science and technology innovation development plan
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. Bhawe K, Roy D (2018) Interplay between NRF1, E2F4 and MYC transcription factors regulating common target genes contributes to cancer development and progression. Cell Oncol (Dordr) 41(5):465–84
2. Cavalcante IP, Rizk-Rabin M, Ribes C, Perlemoine K, Hantel C, Berthon A et al (2022) Tumor suppressor gene ARMC5 controls adrenal redox state through NRF1 turnover. Endocrine-Related Cancer 29(11):615–24
3. Fu J, Zheng H, Cui Q, Chen C, Bao S, Sun J et al (2018) Nfe2l1-silenced insulinoma cells acquire aggressiveness and chemoresistance. Endocrine-Related Cancer 25(3):185–200
4. Grasset EM, Dunworth M, Sharma G, Loth M, Tandurella J, Cimino-Mathews A et al (2022) Triple-negative breast cancer metastasis involves complex epithelial–mesenchymal transition dynamics and requires vimentin. Sci Transl Med 14(656):7571
5. Hu S, Feng J, Wang M, Wufuer R, Liu K, Zhang Z et al (2022) Nrf1 is an indispensable redox-determining factor for mitochondrial homeostasis by integrating multi-hierarchical regulatory networks. Redox Biol 57:102470